Citius Pharmaceuticals, Inc. SEC filings CTXR
Citius Pharmaceuticals, Inc. has 638 filings in SEC EDGAR's recent list, going back to Nov 23, 2010. Its latest annual report, Form ARS, was filed on Feb 24, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Other events
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 26, 2026 | Oct 26, 2026 |
| 8-K |
Current report
Listing notice
|
Aug 21, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| UPLOAD | Letter from the SEC | Aug 10, 2026 | — |
| 8-K |
Current report
Other events
|
Aug 5, 2026 | Aug 5, 2026 |
| EFFECT | Filing | Jun 2, 2026 | — |
| 8-K |
Current report
Other events
|
Jun 1, 2026 | Jun 1, 2026 |
| CORRESP | Letter to the SEC | May 29, 2026 | — |
| S-3 | Shelf registration | May 22, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement
|
May 8, 2026 | May 4, 2026 |
| 8-K |
Current report
Unregistered share sale, Other events
|
Apr 29, 2026 | Apr 23, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 24, 2026 | Apr 23, 2026 |
| 424B5 | Prospectus supplement | Apr 24, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Apr 6, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Other events
|
Mar 31, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Other events
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Other events
|
Mar 4, 2026 | Mar 4, 2026 |
| ARS | Annual report to shareholders | Feb 24, 2026 | Sep 30, 2025 |
| DEFA14A | Additional proxy material | Feb 24, 2026 | — |
| DEF 14A | Proxy statement | Feb 24, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Results of operations, Listing notice
|
Feb 13, 2026 | Feb 9, 2026 |
| 10-Q | Quarterly report | Feb 13, 2026 | Dec 31, 2025 |
| 10-K/A | Amended annual report | Jan 28, 2026 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 23, 2025 | Dec 23, 2025 |
| 10-K | Annual report | Dec 23, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 1, 2025 | Dec 1, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 23, 2025 | Oct 23, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 21, 2025 | Oct 20, 2025 |
| 424B5 | Prospectus supplement | Oct 21, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Other events
|
Jul 8, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 12, 2025 | Jun 9, 2025 |
| 424B5 | Prospectus supplement | Jun 11, 2025 | — |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Jun 3, 2025 | Jun 2, 2025 |
| 8-K |
Current report
Listing notice
|
May 30, 2025 | May 29, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 9, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 18, 2025 | Apr 18, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change to shareholder rights, Bylaw or fiscal year change
|
Apr 18, 2025 | Apr 16, 2025 |
| 8-K |
Current report
Material agreement
|
Apr 3, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 2, 2025 | Apr 1, 2025 |
| 424B5 | Prospectus supplement | Apr 2, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Mar 10, 2025 | Mar 10, 2025 |
| 8-K |
Current report
Other events
|
Feb 14, 2025 | Feb 14, 2025 |
| 10-Q | Quarterly report | Feb 14, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Other events
|
Feb 6, 2025 | Feb 6, 2025 |
| 10-K/A | Amended annual report | Jan 27, 2025 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Jan 27, 2025 | Sep 30, 2024 |
| DEFA14A | Additional proxy material | Jan 27, 2025 | — |
| DEF 14A | Proxy statement | Jan 27, 2025 | Mar 10, 2025 |
| PRE 14A | Preliminary proxy statement | Jan 16, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 8, 2025 | Jan 7, 2025 |
| 424B5 | Prospectus supplement | Jan 8, 2025 | — |
| 8-K |
Current report
Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Results of operations
|
Dec 27, 2024 | Dec 27, 2024 |
| 10-K | Annual report | Dec 27, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 18, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Other events
|
Nov 26, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Other events
|
Nov 25, 2024 | Nov 25, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 18, 2024 | Nov 15, 2024 |
| 424B5 | Prospectus supplement | Nov 18, 2024 | — |
| 8-K |
Current report
Listing notice
|
Nov 13, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Other events
|
Nov 12, 2024 | Nov 11, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 27, 2024 | Sep 25, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 13, 2024 | Sep 9, 2024 |
| 8-K |
Current report
Listing notice
|
Sep 11, 2024 | Sep 10, 2024 |
| 8-K |
Current report
Other events
|
Sep 5, 2024 | Sep 5, 2024 |
| 8-K |
Current report
Material agreement, New debt, Other events
|
Aug 16, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 424B5 | Prospectus supplement | Aug 12, 2024 | — |
| 10-Q | Quarterly report | Aug 12, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Other events
|
Aug 8, 2024 | Aug 8, 2024 |
| 8-K |
Current report
Other events
|
May 21, 2024 | May 21, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Apr 30, 2024 | Apr 25, 2024 |
| 424B5 | Prospectus supplement | Apr 26, 2024 | — |
| 8-K |
Current report
Other events
|
Apr 5, 2024 | Apr 3, 2024 |
| 8-K |
Current report
Other events
|
Mar 18, 2024 | Mar 18, 2024 |
| 8-K |
Current report
Listing notice, Shareholder vote results
|
Mar 13, 2024 | Mar 12, 2024 |
| EFFECT | Filing | Mar 1, 2024 | — |
| CORRESP | Letter to the SEC | Feb 29, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 29, 2024 | — |
| S-3 | Shelf registration | Feb 23, 2024 | — |
| S-8 | Employee stock plan registration | Feb 23, 2024 | — |
| 8-K |
Current report
Results of operations
|
Feb 15, 2024 | Feb 14, 2024 |
| 10-Q | Quarterly report | Feb 14, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Other events
|
Feb 14, 2024 | Feb 14, 2024 |
| ARS | Annual report to shareholders | Jan 26, 2024 | Sep 30, 2023 |
| DEFA14A | Additional proxy material | Jan 26, 2024 | — |
| DEF 14A | Proxy statement | Jan 26, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Other events
|
Jan 23, 2024 | Jan 23, 2024 |
| 8-K | Current report | Jan 5, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Jan 2, 2024 | Jan 2, 2024 |
| 10-K | Annual report | Dec 29, 2023 | Sep 30, 2023 |
| 425 | Current report | Oct 24, 2023 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Oct 24, 2023 | Oct 23, 2023 |
| 8-K |
Current report
Other events
|
Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Listing notice
|
Sep 15, 2023 | Sep 12, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 11, 2023 | Sep 11, 2023 |
| 8-K |
Current report
Other events
|
Sep 8, 2023 | Sep 8, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 15, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Other events
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Other events
|
Jul 31, 2023 | Jul 29, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2023 | Jun 29, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 20, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
May 8, 2023 | May 3, 2023 |
| 424B5 | Prospectus supplement | May 5, 2023 | — |
| 8-K |
Current report
Other events
|
Apr 24, 2023 | Apr 24, 2023 |
| 8-K |
Current report
Other events
|
Apr 3, 2023 | Apr 3, 2023 |
| S-8 | Employee stock plan registration | Feb 10, 2023 | — |
| 8-K |
Current report
Results of operations
|
Feb 10, 2023 | Feb 10, 2023 |
| 10-Q | Quarterly report | Feb 10, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Feb 7, 2023 | Feb 7, 2023 |
| 8-K |
Current report
Results of operations
|
Dec 22, 2022 | Dec 22, 2022 |
| DEFA14A | Additional proxy material | Dec 22, 2022 | — |
| DEF 14A | Proxy statement | Dec 22, 2022 | Feb 7, 2023 |
| 10-K | Annual report | Dec 22, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Other events
|
Dec 1, 2022 | Dec 1, 2022 |
| 8-K |
Current report
Other events
|
Nov 21, 2022 | Nov 21, 2022 |
| 8-K |
Current report
Other events
|
Sep 28, 2022 | Sep 28, 2022 |
| 8-K |
Current report
Other events
|
Sep 22, 2022 | Sep 22, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 25-NSE | Delisting notice | Aug 8, 2022 | — |
| 8-K |
Current report
Other events
|
Jul 12, 2022 | Jul 12, 2022 |
| 8-K |
Current report
Other events
|
May 25, 2022 | May 25, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Other events
|
May 6, 2022 | May 6, 2022 |
| 8-K |
Current report
Other events
|
Apr 26, 2022 | Apr 26, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 13, 2022 | Apr 12, 2022 |
| 8-K |
Current report
Other events
|
Apr 6, 2022 | Apr 6, 2022 |
| 8-K |
Current report
Other events
|
Feb 15, 2022 | Feb 15, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 10, 2022 | Feb 10, 2022 |
| 10-Q | Quarterly report | Feb 10, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Feb 8, 2022 | Feb 8, 2022 |
| DEFA14A | Additional proxy material | Dec 20, 2021 | — |
| DEF 14A | Proxy statement | Dec 20, 2021 | Feb 8, 2022 |
| 10-K | Annual report | Dec 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Dec 15, 2021 | Dec 15, 2021 |
| 8-K |
Current report
Other events
|
Dec 6, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Material agreement
|
Sep 7, 2021 | Sep 1, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 424B4 | Prospectus | Jul 23, 2021 | — |
| EFFECT | Filing | Jul 8, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 7, 2021 | Jul 7, 2021 |
| POS AM | Post-effective amendment no. 2 to form s-1 | Jul 2, 2021 | — |
| 8-K |
Current report
Other events
|
Jul 1, 2021 | Jul 1, 2021 |
| S-8 | Employee stock plan registration | Jun 22, 2021 | — |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 22, 2021 | May 24, 2021 |
| 8-K |
Current report
Other events
|
Jun 8, 2021 | Jun 8, 2021 |
| 8-K |
Current report
Other events
|
Jun 7, 2021 | Jun 7, 2021 |
| DEFA14A | Additional proxy material | May 28, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
May 24, 2021 | May 24, 2021 |
| EFFECT | Filing | May 20, 2021 | — |
| 424B3 | Prospectus | May 20, 2021 | — |
| CORRESP | Letter to the SEC | May 19, 2021 | — |
| UPLOAD | Letter from the SEC | May 18, 2021 | — |
| S-3 | Shelf registration | May 13, 2021 | — |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| EFFECT | Filing | Apr 16, 2021 | — |
| 424B3 | Prospectus | Apr 16, 2021 | — |
| CORRESP | Letter to the SEC | Apr 12, 2021 | — |
| DEFA14A | Additional proxy material | Apr 12, 2021 | — |
| DEF 14A | Proxy statement | Apr 12, 2021 | May 24, 2021 |
| UPLOAD | Letter from the SEC | Apr 9, 2021 | — |
| S-3 | Shelf registration | Apr 2, 2021 | — |
| 424B3 | Prospectus | Apr 1, 2021 | — |
| 424B3 | Prospectus | Mar 26, 2021 | — |
| PRE 14A | Preliminary proxy statement | Mar 12, 2021 | Mar 12, 2021 |
| SEC STAFF LETTER | Filing | Mar 12, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Feb 19, 2021 | Feb 16, 2021 |
| 424B5 | Prospectus supplement | Feb 18, 2021 | — |
| S-3MEF | Registration statement | Feb 16, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 16, 2021 | Feb 16, 2021 |
| 10-Q | Quarterly report | Feb 11, 2021 | Dec 31, 2020 |
| SEC STAFF LETTER | Filing | Feb 11, 2021 | — |
| 8-K |
Current report
Shareholder vote results
|
Feb 9, 2021 | Feb 9, 2021 |
| EFFECT | Filing | Feb 5, 2021 | — |
| 424B3 | Prospectus | Feb 5, 2021 | — |
| CORRESP | Letter to the SEC | Feb 3, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 3, 2021 | — |
| D | Filing | Feb 1, 2021 | — |
| S-3 | Shelf registration | Jan 29, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 27, 2021 | Jan 24, 2021 |
| 8-K |
Current report
Other events
|
Jan 11, 2021 | Jan 11, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTXR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Cranford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506251
- Former names
- Trail One, Inc. (until Sep 18, 2014); TrailOne, Inc. (until Jan 21, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.